investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Targeting Drug-Insensitive CML Stem Cells with Combination Therapy of New ABL and PP2A Inhibitors

Xiaoyan Jiang

0 Collaborator(s)

Funding source

Canadian Institutes of Health Research (CIHR)

No posts

Related projects

Robert M Williams

Multiple Myeloma and Cancer Therapies via Largazole Analogs

Leukaemia

Pathology Hematology and hematologic malignancies

Breanne Landry

A New Approach for Acute Myeloid Leukemia Treatment: siRNA Nanoparticles to Turn-Off Infinite Proliferation and Evasion of Apoptosis

Leukaemia

Li Zhang

A new cellular immunotherapy to treat acute myeloid leukemia

Leukaemia

Niall Dillon

Gene Regulation and Chromatin

Leukaemia

Wenwei Hu

The Role of LIF, a Novel Negative Regulator of p53, in Colorectal Cancer

Leukaemia Colorectum

Peng Huang

ROS, Redox Regulation and Novel Targets for Cancer Therapy

Leukaemia

Benjamin Levine Ebert

Development of Novel Therapeutic Strategies in Human Leukemias

Leukaemia

Wilburn E. Reddick

ALL therapy and developing brains: MRI measures, genetic factors and cognition

Leukaemia Brain, nervous system

Pediatric oncology or childhood cancer

Louise Bowman

Large randomised clinical trials in other (non-vascular) conditions

Leukaemia

Pediatric oncology or childhood cancer